Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Polypipe Group Plc LSE:PLP London Ordinary Share GB00BKRC5K31 ORD GBP0.001
  Price Change % Change Share Price Shares Traded Last Trade
  -1.50 -0.3% 498.50 22,514 08:48:15
Bid Price Offer Price High Price Low Price Open Price
497.00 499.50 502.00 497.00 497.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Industrial Engineering 447.60 60.10 24.90 20.0 1,136
Last Trade Time Trade Type Trade Size Trade Price Currency
08:47:29 AT 16 498.50 GBX

Polypipe (PLP) Latest News

More Polypipe News
Polypipe Investors    Polypipe Takeover Rumours

Polypipe (PLP) Discussions and Chat

Polypipe Forums and Chat

Date Time Title Posts
17/11/202011:46Plastic Pipes are booming business485

Add a New Thread

Polypipe (PLP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
08:47:29498.501679.76AT
08:47:29498.502851,420.73AT
08:47:29498.5051254.24AT
08:47:29498.50167832.50AT
08:47:29498.504001,994.00AT
View all Polypipe trades in real-time

Polypipe (PLP) Top Chat Posts

DateSubject
30/11/2020
08:20
Polypipe Daily Update: Polypipe Group Plc is listed in the Industrial Engineering sector of the London Stock Exchange with ticker PLP. The last closing price for Polypipe was 500p.
Polypipe Group Plc has a 4 week average price of 448.50p and a 12 week average price of 397.50p.
The 1 year high share price is 619p while the 1 year low share price is currently 372p.
There are currently 227,966,162 shares in issue and the average daily traded volume is 305,557 shares. The market capitalisation of Polypipe Group Plc is £1,136,411,317.57.
17/11/2020
11:46
martindjzz: This is a very quiet board! Anyway, PLP seems to have managed the business well this year. Furthermore in the Capital Markets presentation that finished just now they offered a very attractive vision of the future based on some powerful drivers of structural growth. Having been in since mid 2015 I have increased my holding by 20%.
21/7/2020
09:01
philanderer: Down again today.. JEFFERIES CUTS POLYPIPE PRICE TARGET TO 519 (576) PENCE - 'BUY'
17/6/2020
23:40
philanderer: Analysts at Berenberg reiterated their 'hold' rating on plastic piping manufacturer Polypipe on Wednesday, noting that although near-term uncertainty remained, the group was poised to be a "mid-term winner". Berenberg said that after hosting a virtual "fireside chat" with Polypipe chief financial officer Paul James, on 16 June, it felt positive about medium-term structural opportunities presented to the group as it continues its transition into a "one-stop-shop". The German bank said Polypipe's transition should also be aided by its "strong balance sheet" since its £120m equity raise in May but still warned that nearer-term, uncertainty was "high" and said it remained "cautious" on the pace of the recovery in key end-markets. "Management said that the high uncertainty means that it is taking a cautious approach to capex budgets and M&A, with the next two to three months being crucial for how it chooses to proceed," said the analysts. "When assessing this against current valuation, we see better risk/reward elsewhere in the sector," added Berenberg, which kept its 480p target price on the group unchanged. HTTPS://www.sharecast.com/news/broker-recommendations-/broker-tips-polypipe-premier-oil-boohoo--7544418.html
09/6/2020
09:03
philanderer: Berenberg downgrades Polypipe Berenberg has downgraded piping manufacturer Polypipe (POLY) as it believes it will have limited involvement in new infrastructure projects. Analyst Lushanthan Mahendrarajah downgraded his recommendation from ‘buy’ to ‘hold’ and reduced his target price from 520p to 480p. The shares fell 2.1% to 445.5p yesterday. ‘There remains opportunities in UK construction but stock picking is crucial,’ he said. ‘Our preferences lie with those where we see more of a fiscal opportunities via infrastructure, such as Breedon, or regulatory tailwinds, or those names that have underperformed but where we believe end-markets will be relatively more resilient, such as Volution and Travis Perkins.’ HTTPS://citywire.co.uk/funds-insider/news/the-expert-view-astrazeneca-plus500-and-polypipe/a1365741?section=funds-insider&_ga=2.115446405.267598514.1591693106-1130311165.1591693106#i=4
19/5/2020
13:19
philanderer: Numis upgrades ‘well placed’ Polypipe Numis has upgraded Polypipe (PLP) after its recent equity raise as it believes it can continue to drive outperformance. Analyst Christen Hjorth upgraded his recommendation from ‘add’ to ‘buy’ with a target price of 525p on the shares, which surged 7.6% to 430p yesterday. Hjorth said Polypipe would benefit from a range of long-term drivers such as ‘government focus on water management’ and thanks to the capital raise had an ‘improved balance sheet position’ although there were ‘short-term factors impacting the business’. ‘We conclude that the group is well-placed to drive continued outperformance and represents one of the highest quality companies in our building and construction universe,’ he said. HTTPS://citywire.co.uk/funds-insider/news/the-expert-view-superdry-polypipe-and-compass/a1358398?section=funds-insider&_ga=2.241683654.554871396.1589894234-585446346.1589894234#i=3
07/5/2020
18:14
philanderer: FWIW Investors Chronicle: Tip Update: Hold at 474p Polypipe (PLP) has been operating at around 70 per cent below normal levels, supplying customers primarily from existing stock. Residual demand has been driven by urgent NHS and healthcare activity, ongoing infrastructure and commercial work and essential repair, maintenance and improvement projects. Excluding lease liabilities, net debt had increased by over a fifth since the December year-end to £184m as at 31 March, attributed to seasonal working capital flows. An additional £50m revolving credit facility brings the total to £350m for the next 12 months. Despite this additional liquidity, the group is looking to raise £120m from an equity placing to avoid breaching its quarterly covenants through to June 2021. Under a “prudent” scenario, the proceeds would reduce peak 2021 net debt from over 6 times cash profits (Ebitda) to 2.5 times – this is versus a covenant limit of 3 times. IC View Polypipe is assuming demand only starts to recover from July, with trading from September and throughout 2021 still 25 per cent lower than 2019 in its larger residential systems business. Move to hold at 474p. Last IC view: Buy, 466p, 17 Mar 2020 HTTPS://www.investorschronicle.co.uk/tips-ideas/2020/05/07/polypipe-looks-to-raise-funds/
07/5/2020
13:10
mad foetus: I'm amazed it isn't near to £3 right now. The delay in announcing price suggests it's not the easiest sell
07/5/2020
07:39
scooper72: Managed to get 476p for mine just now. Will find out in next weeks or months if I was too cautious. Just currently the climate is so full of uncertainties. And will probably start to buy back in with small buys as the price drops. 3-5 years down the track I am sure they will be in a good place.
18/3/2020
09:00
philanderer: Don’t overlook Polypipe’s strong balance sheet, says Numis Short-term volatility in the shares of Polypipe (PLP) will be overridden by its strong balance sheet, says Numis. Analyst Christen Hjorth reiterated his ‘add’ recommendation and target price of 525p on the shares, which rose 4% to 485p yesterday. The pipe manufacturer announced in line results and Hjorth said ‘notwithstanding the coronavirus, management believes that the group is well-placed over the medium term’. ‘While we see scope for downside risk to estimates due to the pandemic, we retain our current forecasts at this stage,’ he said. ‘Looking forward, share prices are likely to remain volatile in the short-term, but we believe that Polypipe is well positioned from a structural, environmental, and balance sheet perspective.’ HTTPS://citywire.co.uk/funds-insider/news/the-expert-view-compass-polypipe-and-balfour-beatty/a1336390?section=funds-insider&_ga=2.7878203.807879903.1584521860-2011866155.1584521860#i=3
14/8/2019
06:37
robow: from Citywire Polypipe valuation attractive, says Numis Piping manufacturer Polypipe (PLP) is still trading on an attractive multiple despite the shares rising 23% in the last year, says Numis. Analyst Christen Hjorth reiterated his ‘add’ recommendation and target price of 450p on the stock after first-half results were ‘broadly in line’ with estimates. ‘The group alludes to an encouraging start to the second half and we therefore leave our profit forecasts unchanged,’ he said. ‘Polypipe has been a strong performer year-to-date, with its share price up 23%. Despite this, the group trades on what we view as an attractive 2020 price/earnings ratio of circa 12 times and dividend yield of 3.3%.’
Polypipe share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
PLP
Polypipe
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201130 09:04:47